Core Laboratories N.V. (CLB)

Core Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	513.77	509.79	489.74	470.25	487.27	668.21
Revenue Growth (YoY)	0.78%	4.10%	4.14%	-3.49%	-27.08%	-4.66%
Cost of Revenue	405.65	399.96	393.66	367.9	385.14	495.58
Gross Profit	108.12	109.83	96.08	102.36	102.13	172.63
Selling, General & Admin	38.8	38.89	37.57	43.87	32.53	46.52
Depreciation & Amortization	15.42	15.78	17.16	18.52	20.87	22.61
Other Operating Expenses	-1.66	-1.21	-1.71	-1.32	-0.9	1.49
Operating Expenses	52.56	53.47	53.03	61.06	52.5	70.61
Operating Income	55.55	56.36	43.05	41.3	49.63	102.02
Interest Expense	-13.4	-13.43	-11.57	-9.15	-14.37	-14.69
Earnings From Equity Investments	0.39	0.39	0.29	0.06	0.13	0.21
Currency Exchange Gain (Loss)	-0.18	-0.18	-0.23	0.23	-1.16	-1.73
EBT Excluding Unusual Items	42.38	43.15	31.55	32.44	34.22	85.81
Merger & Restructuring Charges	-	-	-3.33	-	-3.94	-5.56
Impairment of Goodwill	-	-	-	-	-114	-
Gain (Loss) on Sale of Assets	0.2	0.2	1.07	1.44	1.25	1.74
Asset Writedown	-2.29	-2.29	-	-	-8.2	-
Other Unusual Items	-0.46	-0.46	-	-	-0.5	-
Pretax Income	40.44	41.21	29.95	36.11	-91.18	81.99
Income Tax Expense	16.1	4.19	10.3	15.89	5.9	-12.29
Earnings From Continuing Operations	24.33	37.03	19.66	20.22	-97.07	94.28
Earnings From Discontinued Operations	-	-	-	-	-0.42	7.83
Net Income to Company	24.33	37.03	19.66	20.22	-97.5	102.12
Minority Interest in Earnings	-0.63	-0.35	-0.21	-0.49	-0.14	-0.13
Net Income	23.71	36.68	19.45	19.73	-97.64	101.98
Net Income to Common	23.71	36.68	19.45	19.73	-97.64	101.98
Net Income Growth	-39.97%	88.53%	-1.39%	-	-	28.24%
Shares Outstanding (Basic)	47	47	46	46	44	44
Shares Outstanding (Diluted)	48	48	47	47	44	45
Shares Change (YoY)	1.34%	1.52%	0.26%	4.98%	-0.38%	0.39%
EPS (Basic)	0.51	0.79	0.42	0.43	-2.20	2.30
EPS (Diluted)	0.50	0.77	0.42	0.42	-2.20	2.29
EPS Growth	-40.70%	83.40%	-0.04%	-	-	27.68%
Free Cash Flow	29.78	14.21	14.74	23.04	45.99	67.26
Free Cash Flow Per Share	0.63	0.30	0.31	0.49	1.03	1.51
Dividend Per Share	0.040	0.040	0.040	0.040	0.280	2.200
Dividend Growth	0%	0%	0%	-85.71%	-87.27%	0%
Gross Margin	21.04%	21.54%	19.62%	21.77%	20.96%	25.83%
Operating Margin	10.81%	11.06%	8.79%	8.78%	10.18%	15.27%
Profit Margin	4.61%	7.19%	3.97%	4.19%	-20.04%	15.26%
Free Cash Flow Margin	5.80%	2.79%	3.01%	4.90%	9.44%	10.07%
EBITDA	70.97	72.15	60.22	59.81	70.49	124.62
EBITDA Margin	13.81%	14.15%	12.30%	12.72%	14.47%	18.65%
D&A For EBITDA	15.42	15.78	17.16	18.52	20.87	22.61
EBIT	55.55	56.36	43.05	41.3	49.63	102.02
EBIT Margin	10.81%	11.06%	8.79%	8.78%	10.18%	15.27%
Effective Tax Rate	39.82%	10.16%	34.37%	44.01%	-	-
Revenue as Reported	509.79	509.79	489.74	470.25	487.27	668.21

Source: S&P Capital IQ. Standard template.